NASDAQ: PIRS - Pieris Pharmaceuticals, Inc.

半年間の収益性: +58.69%
セクタ: Healthcare

プロモーションスケジュール Pieris Pharmaceuticals, Inc.

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について

Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in human blood plasma and other bodily fluids. Its lead respiratory Anticalin based drug candidate, elarekibep used for the treatment of asthma; and PRS-220, an oral inhaled Anticalin protein targeting connective tissue growth factor for the treatment of idiopathic pulmonary fibrosis.

さらに詳しく
The company also develops PRS-344/S09501 2that consists of a PD-L1-targeting antibody and 4-1BB-targeting Anticalin proteins. It has a license and collaboration agreement with Les Laboratoires Servier and Institut de Recherches Internationales Servier, AstraZeneca AB, and Seagen Inc.; and license agreements with Technical University of Munich and Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. Pieris Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Boston, Massachusetts.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

IPO date 2015-04-13
ISIN US7207951036
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.pieris.com
Цена ао 0.188
1日あたりの価格変動: 0% (13.6)
週ごとの価格変動: 0% (13.6)
月ごとの料金変更: -19.19% (16.83)
3ヶ月間の価格変動: -15.84% (16.16)
半年間の価格変動: +58.69% (8.57)
年間の価格変動: +7 372.53% (0.182)
3年間の価格推移: +296.5% (3.43)
5年間の価格推移: +242.57% (3.97)
10年間の価格推移: 0% (13.6)
年初からの価格変動: -17.22% (16.43)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 0.3316 10
P/BV 0.5305 10
P/E 0 0
EV/EBITDA 0.2277 10
合計: 6.25

効率

名前 意味 学年
ROA, % -63.45 0
ROE, % -91.72 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -0.9315 10
合計: 9.6

成長の衝動

名前 意味 学年
収益性 Revenue, % -7.54 0
収益性 Ebitda, % -12.79 0
収益性 EPS, % 4546.31 10
合計: 2.2
さらに詳しく

機関 音量 共有, %
BVF Inc. 20609863 20.83
Lynx1 Capital Management Lp 9775849 9.88
Citadel Advisors Llc 1189887 1.2
Renaissance Technologies, LLC 1065007 1.08
Blackrock Inc. 1037747 1.05
Acadian Asset Management. LLC 962358 0.97
Vanguard Group Inc 907390 0.92
Geode Capital Management, LLC 761444 0.77
CM Management, LLC 750000 0.76
Northern Trust Corporation 243592 0.25



スーパーバイザー 役職 支払い 生年
Mr. Stephen S. Yoder J.D. CEO, President & Director 744.13k 1976 (49 年)
Mr. Thomas Bures Senior VP, CFO & Treasurer 487.5k 1975 (50 年)
Maria Kelman Executive Director of Investor Relations N/A
Dr. Shane Olwill Ph.D. Senior VP & Chief Development Officer 463.91k 1976 (49 年)
Mr. Prompong Chaikul Chief Supply Chain Officer N/A 1987 (38 年)

住所: United States, Boston. MA, 225 Franklin Street - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.pieris.com